Radiation therapy and RF ablation developer RITA Medical Systems of Mountain View, CA, reported that the Blue Cross and Blue Shield (BCBS) Association Technology Evaluation Center (TEC) has completed a review of the scientific data supporting radiofrequency ablation (RFA).
The center concluded that the treatment meets the Medical Advisory Panel’s evaluation criteria as therapy for unresectable hepatic malignancies.
The TEC provides technology assessment services to independent BCBS member plans, as well as other subscriber payors. The assessment is a resource for medical directors and review committees when evaluating new technology, RITA said.
By AuntMinnie.com staff writersNovember 13, 2003
Related Reading
RITA slows losses in Q3, October 23, 2003
RITA names Pedroff as VP, September 18, 2003
RITA taps Soto, September 11, 2003
RITA debuts StarBurst Semi-Flex, September 3, 2003
RITA taps DeVivo as president, CEO, September 3, 2003
Copyright © 2003 AuntMinnie.com
